Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03331731
Title A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma (PLIMATH)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries NZL | AUS

Facility Status City State Zip Country Details
Concord Hospital Concord New South Wales 2139 Australia Details
Linear Clinical Research Nedlands Perth 6009 Australia Details
Royal Brisbane and Women's Hospital Herston Queensland 4029 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Alfred Health Melbourne Victoria 3004 Australia Details
Auckland City Hospital Auckland 1023 New Zealand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field